# $mreo

Mereo BioPharma faces a class action lawsuit filed against investors who acquired shares within a specific period. Meanwhile, the stock is also being eyed as a potential 'buy the dip' opportunity amidst broader market signals.

### About $mreo
MREO is a biotechnology company focused on developing treatments for various diseases.  

### Top $mreo Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$QNCX took some yesterday potential move off bottom like $IOBT $MREO following bad results"  
[X Link](https://x.com/thommic/status/2019770853227941979) [@thommic](/creator/x/thommic) 2026-02-06T13:51Z 12K followers, [---] engagements


"Buy the Dip Signals for [--] Feb 2026- [--] $LUMN at [----] $MARA at [----] $MARO at [---] $MIST at [----] $MREO at [----] $MSTR at [----] $MSTU at [----] $MSTX at [----] $MSTY at [-----] $NAKA at [----] $NBY at [----] $NPWR at [----] $NUKK at [----] $NUTX at [----] $NVCR at 9.27"  
[X Link](https://x.com/anyuser/status/2019621780936347842) [@undefined](/creator/x/undefined) 2026-02-06T03:58Z [---] followers, [---] engagements


"$MREO - Mereo BioPharma Group plc - Class action filed against the company on behalf of investors who acquired Mereo BioPharma American Depositary Shares ("ADS") between June [--] [----] and December [--] [----] (the "Class Period"). Details at #NYSE #Nasdaq #StockMarket #Stocks #StocksInFocus #InvestorAlert #InvestorProtection https://kehoelawfirm.com/class-action-complaints/ https://kehoelawfirm.com/class-action-complaints/ https://kehoelawfirm.com/class-action-complaints/ https://kehoelawfirm.com/class-action-complaints/"  
[X Link](https://x.com/klfclassaction/status/2019524539739238844) [@klfclassaction](/creator/x/klfclassaction) 2026-02-05T21:32Z [---] followers, [---] engagements


"$IOVA bring it on Much like $IBRX #Anktiva TIL (Amtagvi) is exceptional science Much like $IBRX $IOVA has a mastermind investor Mr Rothbaum Quogue Capital. I think his average is still 6$ per share (not sure) $HIMS $NVO $QURE $SLS $SGMO $MREO https://www.forbes.com/profile/wayne-rothbaum/ $IOVA May see rolling catalysts like $IBRX UK Approval Q1 '26 Australia (Prio Rev) Appr Q1 '26 Swiss (Prio Rev) Appr Q1 '26 IOV-END-201 Data Q1 '26 Earnings McKesson ramp-up impact + Canada Cash till Q2 [----] It dawned on me that shitty 24/25 may be a blessing in '26"  
[X Link](https://x.com/BAMBossie81/status/2019475104695013778) [@BAMBossie81](/creator/x/BAMBossie81) 2026-02-05T18:15Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing